Three in 10 U.S. Adults Aware of Menthol-Mimicking Cigarettes
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 14, 2025 -- A substantial proportion of U.S. adults are aware of and have already experimented with synthetic cooling agent menthol-mimicking cigarettes, according to a study published online Jan. 14 in JAMA Network Open.
Kelvin Choi, Ph.D., from the National Institute on Minority Health and Health Disparities in Bethesda, Maryland, and colleagues examined the epidemiology of the use of synthetic cooling agent menthol-mimicking cigarettes among U.S. adults. The analysis included a nationally representative survey sample of 3,200 U.S. adults (aged 21 years and older).
The researchers found that 29.1 percent of U.S. adults were aware of synthetic cooling agent menthol-mimicking cigarettes, with 36.9 percent of those who were aware reporting ever use of these cigarettes, 24.7 percent reporting currently using these cigarettes, and 37.5 percent reporting not currently using but being susceptible to using them. Higher odds of awareness, ever use, current use, and/or susceptibility to these cigarettes was seen among Black or African American (versus White) adults, men (versus women), adults aged 60 years and younger (versus adults aged 61 years and older), adults who used menthol and nonmenthol cigarettes (versus adults who did not smoke cigarettes), and those who lived in states with a menthol cigarette ban (versus those living in states with no ban).
"These products may serve as a substitute for menthol cigarettes and reduce the public health benefits of a menthol cigarette ban in promoting smoking cessation," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-15 06:00
Read more
- AI-Driven Detection of Ovarian Cancer Surpasses Human Expert-Level Accuracy
- Life Expectancy Increased From 2022 to 2023, Reaching 78.4 Years
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
- Heat Waves Threaten Brain Health, Study Suggests
- Bird Flu Kills 20 Million Chickens in U.S., Driving Egg Prices Sky-High
- How to Spot, and Talk About, Hearing Loss in a Loved One
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions